The Globe: Infection, Inflammation, and Systemic Disease

Seminars in Ultrasound, CT and MRI

Volumn 32, Issue 1, 2011, Pages 38-50

  Platnick, Joseph ^a   Crum, Alison V ^a   Soohoo, Stephanie ^a   Cedeño, Paul Anthony ^a   Johnson, Michele H ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARBONATE DEHYDRATASE INHIBITOR; CORTICOSTEROID DERIVATIVE; IMMUNOSUPPRESSIVE AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN DERIVATIVE; VASCULOTROPIN ANTIBODY;

ARTICLE; CATARACT; COMPUTER ASSISTED TOMOGRAPHY; CYTOMEGALOVIRUS RETINITIS; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; ECHOOCULOGRAPHY; ENDOPHTHALMITIS; EYE EDEMA; EYE PAIN; GLAUCOMA; HUMAN; IRIDOCYCLITIS; KERATITIS; KERATOCONJUNCTIVITIS; LOW LEVEL LASER THERAPY; NUCLEAR MAGNETIC RESONANCE IMAGING; ORBIT CELLULITIS; ORBIT DISEASE; ORBIT INFECTION; ORBIT INFLAMMATION; ORBIT PSEUDOTUMOR; PRIORITY JOURNAL; RETINA MACULA AGE RELATED DEGENERATION; RHEUMATOID ARTHRITIS; SARCOIDOSIS; SCLERITIS; SYSTEMIC DISEASE; TOXOCARIASIS; TRABECULECTOMY; VISUAL IMPAIRMENT; VISUAL SYSTEM EXAMINATION; WEGENER GRANULOMATOSIS;

CONTRAST MEDIA; DIAGNOSIS, DIFFERENTIAL; EYE; EYE DISEASES; EYE INFECTIONS; HUMANS; INFECTION; INFLAMMATION; MAGNETIC RESONANCE IMAGING; RADIOGRAPHIC IMAGE ENHANCEMENT; TOMOGRAPHY, X-RAY COMPUTED;

EID: 79251496434     PISSN: 08872171     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.sult.2010.12.003     Document Type: Article

References (122)

1. Shields' Textbook of Glaucoma 2005, 702. Lippincott Williams and Wilkins, Philadelphia. (ed 5). R.R. Allingham (Ed.).
2. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, Beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS Report No. 8. Arch Ophthalmol 2001, 119:1417-1436. Age-Related Eye Disease Study Research Group.
3. Ocular Inflammatory Disease and Uveitis Manual 2010, 255. Lippincott Williams and Wilkins, Philadelphia. (1st ed). J. Huang (Ed.).
4. Kanski J.J. Clinical Diagnosis in Ophthalmology 2006, 601. Mosby Elsevier, Shanghai, China.
5. Duvoisin B., Zanella F.E., Sievers K.W. Imaging of the normal and pathological orbit. Eur Radiol 1998, 8:175-188.
6. Atlas S.W. Magnetic Resonance Imaging of the Brain and Spine 1991, Raven, New York.
7. Hershey B.L., Roth T.C. Orbital infections. Semin Ultrasound CT MR 1997, 18:448-459.
8. Sepahdari A.R., Aakalu V.K., Kapur R., et al. MRI of orbital cellulitis and orbital abscess: The role of diffusion-weighted imaging. AJR Am J Roentgenol 2009, 193:W244-W250.
9. Kernt M., Kampik A. Endophthalmitis: Pathogenesis, clinical presentation, management, and perspectives. Clin Ophthalmologe 2010, 4:121-135.
10. Mafee M.F., Karimi A., Shah J., et al. Anatomy and pathology of the eye: Role of MR imaging and CT. Neuroimaging Clin N Am 2005, 15:23-47.
11. Jackson T.L., Eykyn S.J., Graham E.M., et al. Endogenous bacterial endophthalmitis: A 17-year prospective series and review of 267 reported cases. Surv Ophthalmol 2003, 48:403-423.
12. Ness T., Pelz K., Hansen L.L. Endogenous endophthalmitis: Microorganisms, disposition and prognosis. Acta Ophthalmol Scand 2007, 85:852-856.
13. Rumboldt Z., Moses C., Wieczerzynski U., et al. Diffusion-weighted imaging, apparent diffusion coefficients, and fluid-attenuated inversion recovery MR imaging in endophthalmitis. AJNR Am J Neuroradiol 2005, 26:1869-1872.
14. Yoshida M., Shirao Y., Asai H., et al. A retrospective study of ocular toxocariasis in Japan: Correlation with antibody prevalence and ophthalmological findings of patients with uveitis. J Helminthol 1999, 73:357-361.
15. Shields J.A. Ocular toxocariasis. A review. Surv Ophthalmol 1984, 28:361-381.
16. Pivetti-Pezzi P. Ocular toxocariasis. Int J Med Sci 2009, 6:129-130.
17. Wilkinson C.P., Welch R.B. Intraocular Toxocara. Am J Ophthalmol 1971, 71:921-930.
18. Smirniotopoulos J.G., Bargallo N., Mafee M.F. Differential diagnosis of leukokoria: Radiologic-pathologic correlation. RadioGraphics 1994, 14:1059-1079. quiz: 1081-1082.
19. Chung E.M., Specht C.S., Schroeder J.W. From the archives of the AFIP: Pediatric orbit tumors and tumorlike lesions: Neuroepithelial lesions of the ocular globe and optic nerve. Radiographics 2007, 27:1159-1186.
20. Edwards M.G., Pordell G.R. Ocular toxocariasis studied by CT scanning. Radiology 1985, 157:685-686.
21. Templeton P.A., Rao K.C. Computed tomography of Toxocara canus endophthalmitis. J Comput Tomogr 1987, 11:99-101.
22. Kubal W.S. The pathological globe: Clinical and imaging analysis. Semin Ultrasound CT MR 1997, 18:423-436.
23. Holland G.N. AIDS and ophthalmology: The first quarter century. Am J Ophthalmol 2008, 145:397-408.
24. LeBedis C.A., Sakai O. Nontraumatic orbital conditions: Diagnosis with CT and MR imaging in the emergent setting. Radiographics 2008, 28:1741-1753.
25. Birch-Hirschfield A. Zur Diagnostic and Pathologic der Orbital Tumoren. Ber Zusammenkunft Dtsch Opthalmolol Ges 1905, 32:127-135.
26. Mombaerts I., Goldschmeding R., Schlingemann R.O., et al. What is orbital pseudotumor? Surv Ophthalmol 1996, 41:66-78.
27. Yuen S.J., Rubin P.A. Idiopathic orbital inflammation: Distribution, clinical features, and treatment outcome. Arch Ophthalmol 2003, 121:491-499.
28. Yousem D.M., Atlas S.W., Grossman R.I., et al. MR imaging of Tolosa-Hunt syndrome. AJNR Am J Neuroradiol 1989, 10. 1181-1134.
29. Edwards M.K., Zauel D.W., Gilmor R.L., et al. Invasive orbital pseudotumor: CT demonstration of extension beyond orbit. Neuroradiology 1982, 23:215-217.
30. Eshaghian J., Anderson R.L. Sinus involvement in inflammatory orbital pseudotumor. Arch Ophthalmol 1981, 99:627-630.
31. Berger J.W., Rubin P.A., Jakobiec F.A. Pediatric orbital pseudotumor: Case report and review of the literature. Int Ophthalmol Clin 1996, 36:161-177.
32. Kapur R., Sepahdari A.R., Mafee M.F., et al. MR imaging of orbital inflammatory syndrome, orbital cellulitis, and orbital lymphoid lesions: The role of diffusion-weighted imaging. AJNR Am J Neuroradiol 2009, 30:64-70.
33. Bencherif B., Zouaoui A., Chedid G., et al. Intracranial extension of an idiopathic orbital inflammatory pseudotumor. AJNR Am J Neuroradiol 1993, 14:181-184.
34. Henderson J.W. Orbital Tumors (ed 3) 1994, 317-411. Raven, New York.
35. Spencer W.H. Idiopathic orbital inflammation, in Ophthalmic Pathology (ed 4) 1996, 2822-2830. W B Saunders, Philadelphia.
36. Mombaerts I. Orbital Pseudotumor 1996, 101. Kugler Publishing Group, Amsterdam.
37. Mottow L.S., Jakobiec F.A. Idiopathic Inflammatory orbital pseudotumor in Childhood. I Clinical characteristics. Arch Ophthalmol 1978, 96:1410-1417.
38. Uy H.S., Nguyen Q.D., Arbour J., et al. Sclerosing inflammatory pseudotumor of the eye. Arch Ophthalmol 2001, 119:603-607.
39. Hsuan J.D., Selva D., McNab A.A., et al. Idiopathic sclerosing orbital inflammation. Arch Ophthalmol 2006, 124:1244-1250.
40. Cervellini P., Volpin L., Curri D. Sclerosing orbital pseudotumor. Ophthalmologica 1986, 193:39-44.
41. Ryan S.J., Frank R.N., Green W.R. Bilateral inflammatory pseudotumors of the ciliary body. Am J Ophthalmol 1971, 72:586-591.
42. Valvassori G.E., Sabnis S.S., Mafee R.F., et al. Imaging of orbital lymphoproliferative disorders. Radiol Clin North Am 1999, 37:135-150.
43. Yuen S.J., Rubin P.A. Idiopathic orbital inflammation: Ocular mechanisms and clinicopathology. Ophthalmol Clin North Am 2002, 15:121-126.
44. Siatkowski R.M., Capo H., Byrne S.F., et al. Clinical and echographic findings in idiopathic orbital myositis. Am J Ophthalmol 1994, 118:343-350.
45. Bernardino C.R., Davidson R.S., Maus M., et al. Angle-closure glaucoma in association with orbital pseudotumor. Ophthalmology 2001, 108:1603-1606.
46. Watson P.G., Hayreh S.S. Scleritis and episcleritis. Br J Ophthalmol 1976, 60:163-191.
47. Watson P. Diseases of the sclera, in Clinical Ophthalmology, vol 4 1984, 10-27. Harper and Row, Hagerstown, MD.
48. Watson P.G., Hazleman B.L. The Sclera and Systemic Disorders 1976, 409. W B Saunders, Philadelphia.
49. Watson P.G. Doyne Memorial Lecture, 1982. The nature and the treatment of scleral inflammation. Trans Ophthalmol Soc UK 1982, 102:257-281.
50. Benson W.E., Shields J.A., Tasman W., et al. Posterior scleritis. A cause of diagnostic confusion. Arch Ophthalmol 1979, 97:1482-1486.
51. Benson W.E. Posterior scleritis. Surv Ophthalmol 1988, 32:297-316.
52. Chaques V.J., Lam S., Tessler H.H., et al. Computed tomography and magnetic resonance imaging in the diagnosis of posterior scleritis. Ann Ophth 1993, 25:89-94.
53. Johnson M.H., DeFilipp G.J., Zimmerman R.A., et al. Scleral Inflammatory disease. AJNR Am J Neuroradiol 1987, 8:861-865.
54. Jabs D.A., Mudun A., Dunn J.P., et al. Episcleritis and scleritis: Clinical features and treatment results. Am J Ophthalmol 2000, 130:469-476.
55. Maggioni F., Ruffatti S., Viaro F., et al. A case of posterior scleritis: Differential diagnosis of ocular pain. J Headache Pain 2007, 8:123-126.
56. Sadiq Z., Shepherd R., Vardy S. Posterior scleritis-An unusual presentation of facial pain. Br J Oral Maxillofac Surg 2003, 41:62-63.
57. Kubal W.S. The pathological globe: Clinical and imaging analysis. Semin Ultrasound CT MR 1997, 18:423-436.
58. Osman-Saatci A., Saatci I., Kocak N., et al. Magnetic resonance imaging characteristics of posterior scleritis mimicking choroidal mass. Eur J Radiol 2001, 39:88-91.
59. McCluskey P.J., Watson P.G., Lightman S., et al. Posterior scleritis: Clinical features, systemic associations, and outcome in a large series of patients. Ophthalmology 1999, 106:2380-2386.
60. Bucknall R.C. Arthritis and inflammatory eye disease. Rheumatology 2005, 44:1207-1209.
61. Afshari N.A., Afshari M.A., Foster C.S. Inflammatory conditions of the eye associated with rheumatic diseases. Curr Rheumatol Rep 2001, 3:453-458.
62. Reddy S.C., Rao U.R. Ocular complications of adult rheumatoid arthritis. Rheumatol Int 1996, 16:49-52.
63. Mody G.M., Hill J.C., Meyers O.L. Keratoconjunctivitis sicca in rheumatoid arthritis. Clin Rheumatol 1988, 7:237.
64. McGavin D.D.M., Williamson J., Forrester J.V., et al. Episcleritis and scleritis. A study of their clinical manifestations and association with rheumatoid arthritis. Br J Ophthalmol 1976, 60:192-226.
65. Harper S.L., Foster C.S. The ocular manifestations of rheumatoid disease. Int Ophthalmol Clin 1998, 38:1-19.
66. Tauber J., Sainz de la Maza M. An analysis of therapeutic decision making regarding immunosuppressive chemotherapy for peripheral ulcerative keratitis. Cornea 1990, 9:66.
67. Carmody R.F., Mafee M.F., Goodwin J.A., et al. Orbital and optic pathway sarcoidosis: MR findings. AJNR Am J Neuroradiol 1994, 15:775-783.
68. Newman L.S., Rose C.S., Maier L.A. Sarcoidosis. N Engl J Med 1997, 336:1224-1234.
69. Mafee M.F., Dorodi S., Pai E. Sarcoidosis of the eye, orbit and central nervous system. Role of MR imaging. Radiol Clin North Am 1999, 37:73-87.
70. Herbort C.P., Rao N.A., Mochizuki M., et al. International criteria for the diagnosis of ocular sarcoidosis: Results of the first International Workshop on Ocular Sarcoidosis (IWOS). Ocul Immunol Inflamm 2009, 17:160-169.
71. Joint statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and other Granulomatous Disorders (WASOG) adopted by the ATS Board Of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med 1999, 160:736-755. Statement on sarcoidosis.
72. Siltzback L.E., James D.G., Neville E., et al. Course and prognosis of sarcoidosis around the world. Am J Med 1974, 57:847-852.
73. Lutt J.R., Lim L.L., Phal P.M., et al. Orbital inflammatory disease. Semin Arthritis Rheum 2008, 37:207-222.
74. Baughman R.P., Lower E.E., Kaufman A.H. Ocular sarcoidosis. Semin Respir Crit Care Med 2010, 31:452-462.
75. Thomas K.W., Hunninghake G.W. Sarcoidosis. JAMA 2003, 289:3300-3303.
76. Ohara K., Judson M.A., Baughman R.P. Clinical Aspects of Ocular Sarcoidosis. Sarcoidosis 2005, 88-209. Charlesworth Group, Wakefield, UK. M. Dren, U. Costabel (Eds.).
77. Bonfioli A.A., Orefice F. Sarcoidosis. Semin Ophthalmol 2005, 20:177-182.
78. Ohara K., Okubo A., Sasaki H., et al. Intraocular manifestations of systemic sarcoidosis. Jpn J Ophthalmol 1992, 36:452-457.
79. Bradley D., Baughman R.P., Raymond L., et al. Ocular manifestations of sarcoidosis. Semin Respir Crit Care Med 2002, 23:543-548.
80. Jabs D.A., Johns C.J. Ocular involvement in chronic sarcoidosis. Am J Ophthalmol 1986, 102:297-301.
81. Silver M.R., Messner L.V. Sarcoidosis and its ocular manifestations. J Am Optom Assoc 1994, 65:321-327.
82. Seimon E.M., Zoarski G.H., Rothman M.I., et al. Systemic sarcoidosis with bilateral orbital involvement: MR findings. AJNR Am J Neuroradiol 1998, 19:336-337.
83. Lower E.E., Baughman R.P. Prolonged use of methotrexate for sarcoidosis. Arch Intern Med 1995, 155:846-851.
84. Muller-Quernheim J., Kienast K., Held M., et al. Treatment of chronic sarcoidosis with an azathioprine/prednisolone regimen. Eur Respir J 1999, 14:1117-1122.
85. Baughman R.P., Ohmichi M., Lower E.E. Combination therapy for sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2001, 18:133-137.
86. Yee A.M., Pochapin M.B. Treatment of complicated sarcoidosis with infliximab anti-tumor necrosis factor-alpha therapy. Ann Intern Med 2001, 135:27-31.
87. Tarabishy A.B., Schulte M., Papaliodis G.N., et al. Wegener's granulomatosis: Clinical manifestations, differential diagnosis, and management of ocular and systemic disease. Surv Ophthalmol 2010, 55:429-444.
88. Hoffman G.S., Kerr G.S., Leavitt R.Y., et al. Wegener granulomatosis: An analysis of 158 patients. Ann Intern Med 1992, 116:488-498.
89. Provenzale J.M., Mukherji S., Allen N.B., et al. Orbital involvement by Wegener's granulomatosis: Imaging findings. AJR Am J Roentgenol 1996, 166:929-934.
90. Carrington C.B., Liebow A.A. Limited forms of angiitis and granulomatosis of Wegener's type. Am J Med 1966, 41:497-527.
91. Pakrou N., Selva D., Leibovitch I. Wegener's granulomatosis: Ophthalmic Manifestations and management. Semin Arthritis Rheum 2006, 35:284-292.
92. Harman L.E., Margo C.E. Wegener's granulomatosis. Surv Ophthalmol 1998, 42:458-480.
93. Fauci A.S. The vasculitis syndromes. Harrison's Principles of Internal Medicine 1998, 1914-1922. McGraw-Hill, New York. (ed 14). D.L. Kasper, E. Braunwald, A.S. Fauci (Eds.).
94. Matteson E.L., Gold K.N., Block D.A., et al. Long-term survival of patients with Wegener's granulomatosis criteria cohort. Am J Med 1996, 101:129-134.
95. Kallenberg C.G., Rarok A., Stegeman C.A., et al. New insights into the pathogenesis of antineutrophil cytoplasmic autoantibody-associated vasculitis. Autoimmun Rev 2002, 1:61-66.
96. McDonald J.B., Edwards R.W. Wegener's granulomatosis: a triad. JAMA 1960, 173:1205-1209.
97. Harper S.L., Letko E., Samson C.M., et al. Wegener's granulomatosis: The relationship between ocular and systemic disease. J Rheumatol 2001, 28:1025-1032.
98. Reinhold-Keller E., Beuge N., Latza U., et al. An interdisciplinary approach to the care of patients with Wegener's granulomatosis: Long-term outcome in 155 patients. Arthritis Rheum 2000, 43:1021-1032.
99. Fauci A.S., Haynes B.F., Katz P., et al. Wegener's granulomatosis: Prospective clinical and therapeutic experience with 85 patients for 21 years. Ann Intern Med 1983, 98:76-85.
100. Stone J.H. Wegener's Granulomatosis Etanercept Trial Research Group. Limited versus severe Wegener's granulomatosis: Baseline data on patients in the Wegener's granulomatosis etanercept trial. Arthritis Rheum 2003, 48:2299-2309.
101. Haynes B.F., Fishman M.L., Fauci A.S., et al. The ocular manifestations of Wegener's granulomatosis. Fifteen years experience and review of the literature. Am J Med 1977, 63:131-141.
102. Bullen C.L., Liesegang T.J., McDonald T.J., et al. Ocular complications of Wegener's granulomatosis. Q J Med 1993, 90:279-290.
103. Straatsma B.R. Ocular manifestations of Wegener's granulomatosis. Am J Ophthalmol 1957, 44:789-799.
104. Sadiq S.A., Jennings C.R., Jones N.S., et al. Wegener's granulomatosis: The ocular manifestations revisited. Orbit 2000, 19:253-261.
105. Thorne J.E., Jabs D.A. Ocular manifestations of vascultis. Rheum Dis Clin North Am 2001, 27:761-779.
106. Perry S.R., Rootman J., White V.A. The clinical and pathologic constellation of Wegener granulomatosis of the orbit. Ophthalmology 1997, 104:683-694.
107. Stavrou P., Deutsch J., Rene C., et al. Ocular manifestations of classical and limited Wegener's granulomatosis. Q J Med 1993, 86:719-725.
108. Simmons J.T., Leavitt R., Kornblut A.D., et al. CT of the paranasal sinuses and orbits in patients with Wegener's granulomatosis. Ear Nose Throat J 1987, 66:134-140.
109. Woo T.L., Francis I.C., Wilcsek G.A., et al. Australasian orbital and adnexal Wegener's granulomatosis. Ophthalmology 2001, 108:1535-1543.
110. Seo P., Stone J.H. The antineutrophil cytoplasmic antibody-associated vasculitides. Am J Med 2004, 117:39-50.
111. Spalton D.J., Graham E.M., Page N.G., et al. Ocular changes in limited forms of Wegener's granulomatosis. Br J Ophthalmol 1981, 65:553-563.
112. Talar-Williams C., Sneller M.C., Langford C.A., et al. Orbital socket contracture: A complication of inflammatory orbital disease in patients with Wegener's granulomatosis. Br J Ophthalmol 2005, 89:493-497.
113. Reuter M., Biederer J., Both M., et al. Radiology of the primary systemic vasculitides. Rofo 2003, 175:1184-1192.
114. Francis I.C., Kappagoda M.B., Cole I.E., et al. Computed tomography of the lacrimal drainage system: Retrospective study of 107 cases of dacryostenosis. Ophthal Plast Reconstr Surg 1999, 15:217-226.
115. Iida T., Spaide R.F., Kantor J. Retinal and choroidal arterial occlusion in Wegener's granulomatosis. Am J Ophthalmol 2002, 133:151-152.
116. Courcoutsakis N.A., Langford C.A., Sneller M.C., et al. Orbital involvement in Wegener's granulomatosis: MR findings in 12 patients. J Comput Assist Tomogr 1997, 27:452-458.
117. Janknecht P., Mittelviefhaus H., Loffler K.U. Sclerochoroidal granuloma in Wegener's granulomatosis simulating a uveal melanoma. Retina 1995, 15:150-153.
118. Kamei M., Yasuhara T., Tei M., et al. Vitreous hemorrhage from a ciliary granuloma associated with Wegener granulomatosis. Am J Ophthalmol 2001, 132:924-926.
119. Jayne D. Evidence-based treatment of systemic vasculitis. Rheumatology 2000, 39:585-595.
120. Langford C.A. Treatment of ANCA-associated vasculitis. N Engl J Med 2003, 349:3-4.
121. Cordier J.F., Valeyre D., Guillevin L., et al. Pulmonary Wegener's granulomatosis. A clinical and imaging study of 77 cases. Chest 1990, 97:906-912.
122. Langford C.A., Talar-Williams C., Barron K.S., et al. Use of a cyclophosphamide-induction methotrexate-maintenance regimen for the treatment of Wegener's granulomatosis: Extended follow-up and rate of relapse. Am J Med 2003, 114:463-469.